Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
EMCURE Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and stable ROE
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Neutral
Moderate and stable operating margin
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
EMCURE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
EMCURE Bulk, Block & Insider Trades
EMCURE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and APIs. ... Read More
Key personnel
Mr. Berjis Minoo DesaiD
Non-Executive Chairman of the Board
Mr. Satish Ramanlal MehtaD
Chief Executive Officer, Managing Director, Executive Director
Mr. Tajuddin Sabir Shaikh
Chief Financial Officer
Dr. Mukund Keshao GurjarD
Whole Time Director
Mr. Samit Satish MehtaD
Whole Time Director
Mr. Sunil Rajanikant MehtaD
Whole Time Director
Mrs. Namita Vikas ThaparD
Whole Time Director
Dr. Shailesh Kripalu AyyangarD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Emcure Pharmaceuticals Ltd.?
The current share price of Emcure Pharmaceuticals Ltd. is ₹ 1,540.35 as of 09 Jan 2026.
What is the PE ratio of Emcure Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Emcure Pharmaceuticals Ltd. is 36.82 as of the latest financial data.
What is the ROE and ROCE of Emcure Pharmaceuticals Ltd.?
Emcure Pharmaceuticals Ltd. has a Return on Equity (ROE) of 17.90% and a Return on Capital Employed (ROCE) of 19.89% as per the latest financial reports.
What is the market cap of Emcure Pharmaceuticals Ltd.?
The market capitalization of Emcure Pharmaceuticals Ltd. stands at ₹ 29,200.90 Cr.
What is the dividend yield of Emcure Pharmaceuticals Ltd.?
The dividend yield of Emcure Pharmaceuticals Ltd. is - based on the current market price.
What is the RSI of Emcure Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Emcure Pharmaceuticals Ltd. is 68.75.
What is the FII and DII holding in Emcure Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 3.29% and Domestic Institutional Investors (DII) hold 4.07% of Emcure Pharmaceuticals Ltd. shares.
What sector does Emcure Pharmaceuticals Ltd. belong to?
Emcure Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Emcure Pharmaceuticals Ltd. stock?
The beta of Emcure Pharmaceuticals Ltd. stock is 1.06, indicating its volatility relative to the broader market.
